Companies To Watch: Can brain tech deliver billion-dollar returns?

Controlling devices with your mind sounds like sci-fi, until Neuralink made it real. With brain implants now in live human trials and plans to treat paralysis, restore vision, and one day upgrade cognition itself, Elon Musk’s most radical venture is racing to merge mind and machine. Join Dan Koh and Emaad Akhtar as they explore Neuralink’s latest breakthroughs, its bold commercial roadmap, and how it aims to scale to 20,000 surgeries a year. They also reveal how investors can tap into this growing neurotech wave, even if Neuralink isn’t public.See omnystudio.com/listener for privacy information.